Check your medicine cabinets: More than 3,700 bottles of blood pressure medication sold nationwide were recalled last month because the ingredients in the pills don’t break down properly, an enforcement report from the Food and Drug Administration said.
New Jersey-based Macleods Pharma USA Inc. issued the recall, for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets Oct. 7. The recall was categorized as a Class II recall Oct. 26, which means the pills could cause temporary health problems, but serious health consequences are unlikely.
The pills ranged from 40 mg, 10mg and 12.5mg, and were sold in either 30-count or 90-count bottles. Overall, 3,528 30-count bottles were recalled, and 216 90-count bottles were recalled, the report said.
The reason for the recall, the report stated, was because of “failed dissolution specifications.”
According to the Mayo Clinic, the prescription pills are used to treat hypertension, or high blood pressure.
No further details were available. NBC Chicago reached out to Macleods Pharma for comment.
Hence then, the article about fda issues nationwide recall of blood pressure medication after pills fail quality test was published today ( ) and is available on NBC Chicago ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA issues nationwide recall of blood pressure medication after pills fail quality test )
Also on site :